Video: Theresa Heggie of Shire on #OrphanDrug development and commercialization

Theresa Heggie of Shire on orphan disease Theresa Heggie, Senior VP of Global Commercial Operations at Shire Human Genetic Therapies, presented at last year's World Orphan Drug Congress USA on the topic ‘The development and commercialization of drugs for patients with orphan diseases.'

Do you want to learn more about:

  • Encouraging responsibility and urgency to meet patients' needs
  • Partnering long-term with patient organizations, healthcare professionals and payers
  • Engaging employees through Shire's BRAVE culture

If so, you need to check out the video below:

For more information on orphan drugs and rare diseases, check out the World Orphan Drug Congress USA. Remember, the earlier you book, the more you save, so register now to secure your seat!

Leave a Reply

Your email address will not be published. Required fields are marked *